Ready-to-Use Multiplex Assays: Twelve qPCR vials (5-plex format) optimized for consistent and sensitive amplification.
Built-in Internal Amplification Control (Cy5.5): Every 5-plex mix includes an Internal Control detected on the Cy5.5 channel, ensuring real-time monitoring of amplification performance and PCR inhibition.
Positive Control: Whole genome libraries Normalized to 500 genomic copies/ul
Exogenous Control (EC): Spike-in Non-Pathogen Whole organism controls to confirm extraction and amplification efficiency.
Comprehensive Documentation: Includes detailed protocols, troubleshooting guide, and Certificate of Analysis (COA).
Comprehensive Detection of ENT Pathogens and Antimicrobial Resistance Targets
- Bacterial Targets: Acinetobacter baumannii, Bacteroides fragilis, Bordetella pertussis, Bordetella parapertussis, Citrobacter freundii / braakii / koseri, Corynebacterium diphtheriae, Enterobacter cloacae, Enterococcus faecalis / Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Klebsiella oxytoca / Klebsiella pneumoniae, Moraxella catarrhalis, Neisseria gonorrhoeae, Peptostreptococcus spp., Prevotella bivia, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidermidis / Staphylococcus haemolyticus / Staphylococcus saprophyticus, Streptococcus agalactiae (Group B), Streptococcus pneumoniae, Streptococcus pyogenes (Group A), Streptococcus dysgalactiae (Group C/G), Vibrio spp. (including Vibrio vulnificus)
- Parasitic / Opportunistic Targets: Pneumocystis jirovecii
- Viral Targets: Herpes Simplex Virus 1 & 2
- Fungal Targets: Aspergillus spp., Alternaria spp., Candida spp. (C. albicans, C. dubliniensis, C. parapsilosis, C. tropicalis), Cladosporium spp., Cryptococcus neoformans, Cryptococcus gattii, Curvularia spp., Epicoccum spp., Fusarium spp., Malassezia spp., Mucor spp., Coccidioides spp.
- AMR: Beta-lactamase (CTX-M Group 1), Carbapenemase (blaNDM / blaKPC), Metallo-β-lactamase (VIM), Methicillin resistance (mecA), Vancomycin resistance (VanA / VanB / VanM)
- Controls: Internal Control (RNase P), Exogenous Control (EC)
Covers 26 bacterial targets, 7 fungal targets, 1 parasitic target, 1 viral target, 8 antimicrobial resistance markers, and 3 internal controls for comprehensive ENT, upper respiratory, and otolaryngology-associated infection and antimicrobial resistance profiling.
